| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 25, 2026 | HeartLung.AI Marks Unprecedented Scientific Milestone with 10 Presentations at ESC Congress 2026 | HeartLung will present 10 scientific presentations at ESC 2026
10 Presentations ESC 2026
Unprecedented company milestone highlights AI advances in cardiovascular imaging, risk prediction, and preventive care from routine CT scans. MUNICH , ... |
| Aug 7, 2026 | RSNA Features HeartLung.AI Study Linking AI-Quantified Myosteatosis to Future COPD Risk | Visual Abstract
20-year MESA analysis finds CT-derived muscle quality predicts COPD more strongly than emphysema-like lung measures
This is exactly where AI can change medicine”
— Morteza Naghavi, M.D.HOUSTON, TX, UNITED STATES, August 7, 2... |
| Jul 16, 2026 | Two HeartLung.AI Studies Show Routine Chest CT Assesses Cardiac Risk Like Dedicated Cardiac CT and Echocardiography | Complementary MESA analyses validate AI-derived chamber volumetry from non-gated, non-contrast CT for heart failure and atrial fibrillation risk assessment HOUSTON, TX, UNITED STATES, July 16, 2026 /EINPresswire.com/ -- HeartLung.AI announc... |
| Jul 6, 2026 | HeartLung Launches 'Why Pay More and Get Less?' Campaign at SCCT 2026 | Preventive cardiology doesn't need more CCTA, it needs AI-CVD
AI-CAC and AI-CVD
HeartLung Logo
AI-CVD challenges plaque-centric AI-CCTA with CAC-based primary prevention: one non-contrast CT, lower cost and radiation, 10+ reports.
If C... |
| Jun 19, 2026 | AHA Stroke Alert Podcast Features HeartLung.AI Research on AI-Predicted Atrial Fibrillation and Stroke | AI-derived left atrial volume and chamber ratios from CAC scans predicted long-term AF and stroke in MESA and Framingham. HOUSTON, TX, UNITED STATES, June 19, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that its research article... |
| Jun 12, 2026 | After 36 Years, Coronary Calcium Score Gets Its First Major Upgrade (Agatston-2.0) Led by HeartLung.AI and Dr. Agatston | Agatston 2.0
Agatston 2.0 Framework Summary
New study introduces an AI-based coronary calcium scoring method designed to address key limitations of the original Agatston score. HOUSTON, TX, UNITED STATES, June 12, 2026 /EINPresswire.com/ --... |
| May 18, 2026 | Study Shows AI-CVD® Outperforms Diabetes in Predicting Heart Failure Risk | Comparing Incidence of Heart Failure in Individuals with Enlarged Cardiac Chambers versus Diabetes
HOUSTON, TX, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- HeartLung Corporation announced the publication of a new study in the American... |
| May 11, 2026 | HeartLung.AI Emerges as a Leading Innovator in Cardiology with 10 Accepted ESC.26 Abstracts | Accepted studies showcase HeartLung.AI’s leadership in AI-CVD, opportunistic CT screening, Agatston 2.0, chamber volumetry, and preventive cardiology. HOUSTON, TX, UNITED STATES, May 11, 2026 /EINPresswire.com/ -- HeartLung.AI today announc... |
| May 3, 2026 | HeartLung Announces USPTO Issuance of Foundational AI-CVD Patent and Allowance for Vasa Vasorum Inflammation Imaging | AI-CVD Modules
AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AutoChamber AI segmentation showing heart chambers and left ventricular wall
Inflamed atherosclerotic plaques have h... |
| Apr 7, 2026 | HeartLung AI Welcomes CMS Coverage for AI-Enabled Opportunistic Coronary Artery Calcium (CAC) Detection on Chest CT | AutoCAC and AI-CAC by HeartLung
AutoCAC and AI-CAC by HeartLung
HOUSTON, TX, UNITED STATES, April 7, 2026 /EINPresswire.com/ -- HeartLung AI today welcomed CMS’s establishment of HCPCS code G0680 in the April 2026 Hospital Outpatient Prospe... |
| Mar 19, 2026 | Breaking the Mold at ACC.26: HeartLung.AI Emerges as the Only Exhibitor With Seven Scientific Presentations | AI-CVD Modules
NEW ORLEANS , LA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that it will showcase seven scientific presentations at ACC.26, the American College of Cardiology’s 75th Annual Scientific Se... |
| Mar 18, 2026 | HeartLung Applauds New 2026 ACC/AHA Guidelines Urges Using AI-Enabled Opportunistic Screening to Save Lives | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AI-enabled opportunistic detection of coronary calcium and other CT imaging biomarkers enables identification of high-risk patients... |
| Feb 3, 2026 | HeartLung.AI Expands Preventive Imaging AI on Precision Imaging Network, part of Microsoft for Healthcare | AutoChamber™ and AutoBMD™ AI solutions will soon be available on Precision Imaging Network, with AI-CVD® planned next. HOUSTON, TX, UNITED STATES, February 3, 2026 /EINPresswire.com/ -- HeartLung.AI, an AI-enabled company focused on early d... |
| Jan 16, 2026 | FDA Clears HeartLung's AI-CVD®, Enabling the Broadest Opportunistic Cardiovascular & Multisystem CT Screening Platform | FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and skeletal risk in ~40M scans/year
HOUSTON, Jan. 16, 2026 /PRNewswire-PRWeb/ -- HeartLung Corporation today announced U.S. Food... |
| Jan 12, 2026 | FDA Clears HeartLung's AI-CVD®, Enabling the Broadest Opportunistic Cardiovascular & Multisystem CT Screening Platform | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
FDA-cleared AI-CVD® extracts preventive insights from routine CT—identifying hidden cardiovascular, metabolic, and skeletal risk in... |
| Oct 21, 2025 | HeartLung Technologies Sets New Milestone with Nine Accepted Abstracts at AHA 2025 Showcasing the Power of AI-CVD™ | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AI-CAC Diagram
I want to congratulate the AI-CVD team for this groundbreaking accomplishment.”
— Robert A. Kloner, MD, PhD.NEW ORLE... |
| Oct 17, 2025 | American Heart Association Cites HeartLung’s AI-CAC™ and AI-CVD™ in Landmark Statement on Opportunistic Screening | AI-CAC Diagram
AutoBMD AI sample report with Z Score and T Score
AutoChamber sample report
This marks a pivotal moment in preventive medicine”
— Morteza Naghavi, M.D.HOUSTON, TX, UNITED STATES, October 17, 2025 /EINPresswire.com/ -- The Ame... |
| Oct 10, 2025 | AI-CVD Myosteatosis and Hepatosteatosis Findings Linked to Diabetes and Heart Failure Presented at Mount Sinai I-ELCAP | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan. NEW YORK CITY, NY, UNITED STATES, October 10, 2025 /EINPresswire.com/ -- Investigators from the AI-CVD™ consortium presented new re... |
| Oct 2, 2025 | AI-CVD Investigators to Present at I-ELCAP’s 48th International Conference on Screening for Lung Cancer, Oct 9–11 in NYC | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AI-CVD at I-ELCAP highlights a single low-dose CT that bridges lung cancer screening and cardiovascular prevention—register for in ... |
| Aug 27, 2025 | HeartLung.AI to Present Seven Pioneering AI-CVD™ and AI-CAC ™ Studies at European Society of Cardiology 2025 in Madrid | AI-CVD™ components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AI-CAC™ Diagram
HeartLung AI will showcase seven abstracts at ESC 2025 on AI-CVD™, including novel AI-CAC™ for earlier, more sensi... |
| Aug 12, 2025 | HeartLung’s Leadership Featured on Cardiac Wire Show to Discuss New AI for Early Cardiac Chamber Enlargement Detection | HeartLung's Medical Leadership Discusses AutoChamber™ AI on the Cardiac Wire Show
AutoChamber™ Bifold 2025 - Front
Example AutoChamber™ AI Report
AI-CVD™ components includes AutoChamber, AutoBMD, and several other opportunistic measure... |
| Jul 24, 2025 | AI-Powered CT Chamber Volumetry Predicts Heart Failure Risk As Accurately As MRI, New Study Shows | AI-measured left ventricular (LV) volume from non-contrast coronary artery calcium (CAC) scans predicts incident heart failure comparably to cardiac magnetic resonance imaging (MRI) in MESA.
AI-CVD components includes AutoChamber, AutoBMD, ... |
| Jul 24, 2025 | AI Osteoporosis Screening: HeartLung and Imaging Wire on Saving Lives and Reducing Costs | HeartLung's Medical Leadership Discusses AutoBMD AI on the Imaging Wire Show
AutoBMD AI sample report with Z Score and T Score
HeartLung's medical leadership featured on Imaging Wire Show to discuss breakthrough new AI for opportu... |
| May 21, 2025 | Capitol Imaging Services Partners with HeartLung to Offer Opportunistic AI Screening for Osteoporosis and Heart Disease | HeartLung AI's AutoBMD™ and AutoChamber™ reports with the HeartLung and Capitol Imaging Services logos
Capitol Imaging Services PET/CT Services
Front and Back cover of HeartLung's AutoChamber™ AI Brochure
Front and Back cover of H... |
| Apr 2, 2025 | HeartLung Technologies Secures CMS Reimbursement for AutoChamber™ with New HCPCS Code | AutoChamber Bifold 2025 - Front
AutoChamber Bifold 2025 - Back
HeartLung proudly announces that CMS has approved a new HCPCS code for AutoChamber™ AI reporting cardiac chambers volume and left ventricular mass in CT scans
This is an incredi... |
| Mar 25, 2025 | HeartLung Technologies welcomes medical imaging and bioengineering expert Dr. Zahi A. Fayad, PHD, to the Advisory Board | Dr. Zahi A. Fayad, PhD
HeartLung Technologies proudly announces Dr. Zahi A. Fayad, PhD, joining the advisory board to enhance AI-driven preventive healthcare solutions.
I am thrilled to join HeartLung Technologies' advisory board and c... |
| Mar 17, 2025 | HeartLung Technologies Selected as a Finalist for ACC 2025 Innovation Pitch Challenge | ACC 2025 Future Hub Graphic
HeartLung.AI - ACC Early-Stage Innovation Pitch Challenge
AutoChamber AI vs MRI for Atrial Fibrillation and Heart Failure
HeartLung Technologies selected as a finalist and will compete at the ACC 2025 Innovation ... |
| Mar 17, 2025 | HeartLung Technologies to launch AutoChamber™ AI at ACC 2025 and begin offering the AI services to healthcare providers | AutoChamber AI vs MRI for Atrial Fibrillation and Heart Failure
HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamber™) at ACC 2025, offering lifesaving AI solutions for CVD prevention. HOUST... |
| Feb 19, 2025 | SimonMed Imaging, HeartLung Partner to Offer AI-Powered Osteoporosis Screening | What You Should Know:
– SimonMed Imaging, a provider of outpatient medical imaging services, and HeartLung Technologies, a pioneer in AI-powered diagnostics announced a strategic partnership to offer HeartLung’s automated bone mineral densi... |
| Feb 19, 2025 | SimonMed Imaging Partners with HeartLung.AI to Offer Artificial Intelligence-Based Bone Density Screening Nationwide | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
Dr. Simon's team at SimonMed Imaging chose HeartLung's AutoBMD™ AI to detect osteoporosis early, marking a significant mi... |
| Jan 28, 2025 | HeartLung Technologies Welcomes World-Renowned Cardiologist Dr. Robert A. Kloner to the Advisory Board | HeartLung Technologies welcomes Dr. Robert A. Kloner to the Advisory Board. With over 45 years of experience, he brings unparalleled scientific leadership. HOUSTON, TX, UNITED STATES, January 28, 2025 /EINPresswire.com/ -- HeartLung Technol... |
| Nov 30, 2024 | HeartLung Technologies to Present Four Cutting-Edge Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at RSNA 2024 | AI-CVD components includes AutoChamber, AutoBMD, and several other opportunistic measurements in a CAC scan.
AI-CAC with calcium score, calcified plaque characterization, and cardiac chambers volumes.
AutoChamber sample report
AutoBMD AI sa... |
| Oct 30, 2024 | HeartLung Receives FDA “Breakthrough” Marketing Authorization for First AI to Detect Hidden Heart Disease in CT Scans | AutoChamber sample report
AutoChamber AI segmentation showing heart chambers and left ventricular wall
AutoChamber AI segmentation showing left atrial enlargement
AI-CVD components includes AutoChamber, AutoBMD, and several other opportunis... |
| Oct 29, 2024 | HeartLung Technologies Receives FDA "Breakthrough" Status and Marketing Authorization for the First Opportunistic AI to Help Detect Heart Disease in Millions of CT Scans | AutoChamber sample report showing enlarged cardiac chambers in a patient with calcium score zero
HeartLung Technologies (www.heartlung.ai), an AI-enabled health-tech company focused on early detection of heart disease and lung cancer, has s... |
| Aug 31, 2024 | Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London | AI-enabled detection of individuals high risk for atrial fibrillation and stroke
Pioneering research by Dr. Naghavi's team from American Heart Technologies and HeartLung.AI highlights AI's transformative impact on early detection ... |
